Engineers Gate Manager LP

Position in RLAY — Relay Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in RLAY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,407,447

+$744,454 QoQ

Shares Held

141,452

+80.5% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,407,447	141,452	+80.5%	Shares	Sole	2026-05-15
2025-12-31	$662,993	78,368	+102.4%	Shares	Sole	2026-02-17
2025-06-30	$133,967	38,719	+31.5%	Shares	Sole	2025-08-14
2025-03-31	$77,127	29,438	-41.5%	Shares	Sole	2025-05-15
2024-09-30	$356,485	50,351	+4.2%	Shares	Sole	2024-11-14
2024-06-30	$314,916	48,300	-2.2%	Shares	Sole	2024-08-14
2024-03-31	$409,804	49,374	+82.1%	Shares	Sole	2024-05-15
2023-12-31	$298,525	27,114	-53.5%	Shares	Sole	2024-02-14
2023-09-30	$490,731	58,351	+235.4%	Shares	Sole	2023-11-14
2023-03-31	$286,528	17,397	-50.4%	Shares	Sole	2023-05-15
2022-12-31	$524,169	35,085	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.